Search for: "Merck & Company, Inc." Results 21 - 40 of 444
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jan 2016, 2:39 pm by Tom Lamb
We have some additional information about the arguments being made by the plaintiffs' attorneys and the lawyers for the drug company, Merck, as regards one of the pending appeals, now. [read post]
17 Mar 2018, 7:18 am by Howard Bashman
” Nate Raymond of Reuters has a report that begins, “Massachusetts’ top court on Friday opened the door for consumers to sue Merck & Co Inc and other makers of brand-name drugs over injuries blamed not on their own medications but on generic versions of their treatments made by other companies. [read post]
12 Aug 2013, 2:06 pm by Tom Lamb
Judge Sippel recently denied the Company’s motion for summary judgment in the first NuvaRing MDL trial which is expected to take place in January 2014. [read post]
18 Dec 2013, 2:13 pm by Tom Lamb
Serious Injury And Death Cases Involve Blood Clots Leading To DVT And/Or PE Events As Well As Heart Attacks And Strokes In Women Of Various Ages (Posted by Tom Lamb at DrugInjuryWatch.com)The Form 10-Q SEC filing by Merck for the corporate quarterly period ending September 30, 2013 (93 page PDF document) provides us with this latest information about the number of filed NuvaRing lawsuits: As previously disclosed, beginning in May 2007, a number of complaints were filed in various… [read post]
14 Aug 2008, 9:50 pm
Most Of These Product Liability Cases Allege Fosamax Caused Drug-Induced Osteonecrosis Of The Jaw (ONJ) (Posted by Tom Lamb at DrugInjuryWatch.com) According to an August 14, 2008 "MERCK & CO: Faces 655 Product Liability Cases Over Fosamax Drug", published by Lloyds Corporate Litigation Reporter:   Merck & Co., Inc., as of June 30, 2008, faced approximately 655  product liability cases involving Fosamax drug,… [read post]
28 Nov 2011, 4:02 am by Max Kennerly, Esq.
Carter-Wallace, Inc., 97 F.3d 1227, 1230-1234 (9th Cir. 1996)), making it much harder to level the playing field. [read post]
30 Jan 2007, 9:44 am
Continues To Be Pay Defense Lawyers, Not Plaintiffs, Taking Each Case To Trial (Posted by Tom Lamb at DrugInjuryWatch.com) Merck & Co., Inc.'s President and CEO Richard Clark reported to financial analysts during a January 30, 2007 Earnings Conference Call that the drug company has increased its legal reserves for the ongoing Vioxx litigation and new Fosamax lawsuits. [read post]
18 Sep 2017, 11:12 am by Tom Lamb
Its ruling is the latest in a series of plaintiff-friendly decisions that misconstrued the Supreme Court’s landmark 2009 ruling in Wyeth Inc. v. [read post]
22 Dec 2008, 10:46 am
Merck & Company, Inc., 2008 WL 5157705 (9th Cir. 2008). [read post]
9 Nov 2007, 9:55 am
  9, 2007 - Merck & Co., Inc. today announced that it has entered into an agreement with the law firms that comprise the executive committee of the Plaintiffs' Steering Committee of the federal multidistrict VIOXX litigation as well as representatives of plaintiffs' counsel in state coordinated proceedings to resolve state and federal myocardial infarction (MI) and ischemic stroke claims already filed against the Company in the United States. [read post]
11 Sep 2008, 4:55 am
Forest Laboratories, Inc. and Merck & Co. v. [read post]
25 Jun 2021, 4:15 am by Logan Murr
A group of intellectual property professors; GlaxoSmithKline plc; and Biogen Inc., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
16 Dec 2009, 2:51 pm by Sheppard Mullin
Together, the companies account for over 75 percent of all poultry vaccine sales in the United States. [read post]